Yuying C. Hwang
Amgen (United States)(US)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Cancer Research and Treatments, Angiogenesis and VEGF in Cancer, Cardiac Ischemia and Reperfusion, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Receptor for Advanced-Glycation End Products(2006)249 cited
- → Safety, Pharmacokinetics, and Antitumor Activity of AMG 386, a Selective Angiopoietin Inhibitor, in Adult Patients With Advanced Solid Tumors(2009)242 cited
- → Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo(2006)164 cited
- → A First-in-Human Study of Conatumumab in Adult Patients with Advanced Solid Tumors(2010)137 cited
- → Central role for aldose reductase pathway in myocardial ischemic injury(2004)128 cited
- → RAGE and Modulation of Ischemic Injury in the Diabetic Myocardium(2008)109 cited
- → Clinical activity of AMG 337, an oral MET kinase inhibitor, in adult patients (pts) with MET-amplified gastroesophageal junction (GEJ), gastric (G), or esophageal (E) cancer.(2015)109 cited
- → Diels-Alder reaction of 1-azadienes. A total synthesis of deoxynupharidine(1985)105 cited
- → Aldose reductase activation is a key component of myocardial response to ischemia(2001)103 cited
- → In Vivo DA D1 Receptor Selectivity of NNC 112 and SCH 23390(2007)102 cited